Metabiologics is a venture capital-funded biotech firm that has been producing bacterial and virus vaccines, including botulinum toxins, since 1999. Located in the University of Wisconsin Research Park in Madison, Wisconsin, the firm focuses on manufacturing high-purity toxin products for accredited researchers globally. Metabiologics typically invests in a range of stages, including Seed, Series A, and Series B rounds, with a significant number of investments also in debt financing and angel rounds.